PacBio® RS II With BluePippin™ Size Selection Platform Provides Customers Improved Ability to Sequence Longer DNA Fragments MENLO PARK, Calif. and BEVERLY, Mass., May 16, 2013 (GLOB...
Investor Relations
Pacific Biosciences' mission is to transform the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research. The Company has developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. Combining recent advances in nanofabrication, biochemistry, molecular biology, surface chemistry and optics, Pacific Biosciences has created a powerful technology platform called single molecule, real-time, or SMRT™, technology. SMRT technology enables real-time analysis of biomolecules with single molecule resolution, which has the potential to transform the understanding of biological systems by providing a window into these systems that has not previously been open for scientific study.
Recent News
May 6, 2013
New Assembly Method Published for Rapid and Automated Genome Sequencing Using Long-Read, Single Molecule, Real-Time (SMRT(R)) Sequencing
MENLO PARK, Calif., May 6, 2013 (GLOBE NEWSWIRE) -- Researchers from Pacific Biosciences of California, Inc., (Nasdaq:PACB), the U.S. Joint Genome Institute and the University of Washington have publi...
Stock Quote
NASDAQ (GM) : PACB
Price
$2.54
Last Trade
1:15 PM ET
May 22, 2013
May 22, 2013
Change
$0.00
Change (%)
0.000%
Volume
49,800
52 Week High
3.25
52 Week Low
1.06
Day High
2.56
Day Low
2.51
Investor
Contacts
Pacific Biosciences
1380 Willow Rd.
Menlo Park, CA 94025
(650) 521-8450
ir@pacificbiosciences.com
